Pharmacovigilance (BP805ET) - AKTU Question Paper 2023-24
B.Pharm · Semester 8 · Free PDF Download
This is the official AKTU Pharmacovigilance Previous Year Question Paper for B.Pharm Semester 8, academic session 2023-24. Published by Dr. A.P.J. Abdul Kalam Technical University (AKTU/UPTU), Lucknow. Free PDF download — no login required.
Rate this paper
Questions Asked in 2023-24
Pharmacovigilance (BP805ET) — complete question paper · 75 marks · 3 Hours
- aWhat is adverse drug reaction?
- bMention the differences between drug toxicity and drug abuse
- cWhat is eudravigilance?
- dWhat is drug event monitoring?
- eList four drugs contraindicated in padiatric patients
- fWhat is post marketing safety?
- gNarrate the minimum criteria required for a valid report
- hMention the salient features of Phase III of clinical trial. i. What do you mean by t eratogenicity? j. What is ATC classification of drugs?
- aDiscuss the importance of s afety monitoring of medicine. Highlight the salient features of the Pharmacovigilance Program of India (PvPI)
- bHow will you set up the establishment & operation of drug sa fety department in industry? Mention its rationale of such set up
- cDiscuss in detail of Cohort and case control study. Explain the applications of MedDRA and standard MedDra queries
- aSuggest some examples of v accination failure. How will you control such failures in future?
- bMention the importance aspects of ICH guidelines for expedited reporting
- cWhat is the role of CDSCO in pharmacovigilance? Write a note on ATC classification of drugs
- dHow will you carry out drug safety evaluation in pregnant woman and geriatric patients?
- eWrite short notes on CIOMS
- fSuggest the role of genetic s related ADR with examples
- gWrite short note on pharmacogenomics on adverse drug reaction
Question text is extracted from the official AKTU question paper PDF above. Hindi translations are omitted — every question is printed in English in the original paper. Last verified: 2026-08-23.
Repeated Questions — BP805ET
Questions that appeared in more than one session, found by comparing 3 years of Pharmacovigilance papers (2021-22, 2022-23, 2023-24)
What is adverse drug reaction?
Appeared in: 2022-23 · 2023-24
What is eudravigilance?
Appeared in: 2021-22 · 2023-24
What is drug event monitoring?
Appeared in: 2021-22 · 2023-24
List four drugs contraindicated in padiatric patients
Appeared in: 2021-22 · 2023-24
What is post marketing safety?
Appeared in: 2021-22 · 2023-24
Narrate the minimum criteria required for a valid report
Appeared in: 2021-22 · 2023-24
Discuss in detail of Cohort and case control study. Explain the applications of MedDRA and standard MedDra queries
Appeared in: 2021-22 · 2023-24
Mention the importance aspects of ICH guidelines for expedited reporting
Appeared in: 2021-22 · 2023-24
What is the role of CDSCO in pharmacovigilance? Write a note on ATC classification of drugs
Appeared in: 2021-22 · 2023-24
How will you carry out drug safety evaluation in pregnant woman and geriatric patients?
Appeared in: 2021-22 · 2023-24
Write short note on pharmacogenomics on adverse drug reaction
Appeared in: 2021-22 · 2023-24
Pharmacovigilance — Other Year Papers
AKTU Pharmacovigilance PYQs from other sessions
More B.Pharm Semester 8 (2023-24) Papers
Other subjects from same semester and session